IP Library Granted Patent US 11,071,786
Granted Patent B2
US 11,071,786 · App. 16/674,895 · Granted Jul 27, 2021

Dermal skin protectant and carrier

Inventor: Mark A. Latta (Omaha, NE)
Assignee: Inspired Material Solutions, LLC
A61K47/34A61K8/27A61K8/922A61K31/138A61K31/14A61K31/195A61K31/245A61K31/352A61K31/4174A61K31/4425A61K31/5375A61K31/573A61K31/60A61K31/635A61K31/7036A61K31/7048A61K33/38A61K38/12A61K38/363A61K38/4833A61Q3/00A61Q17/00A61Q17/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,071,786
App. No.
16/674,895
Granted
Jul 27, 2021
Kind
B2
Abstract

A dermal skin protectant and carrier comprising a combination of two different viscosity dimethicone components, wherein the difference between the two different viscosity dimethicone components is about 2.0 million cP or greater; and comprising at least one active ingredient.

Claims (25)

1. A dimethicone-based dermal skin protectant and carrier for making a single layer barrier, comprising: a first dimethicone material having a viscosity of between about 1,000 cP and 25,000 cP, and a second dimethicone material having a viscosity of between about 2.0 million and 3.0 million cP; and at least one active agent wherein the concentration of the first dimethicone material is between 47.5% and 92.5% of the weight of the skin protectant and carrier.

2. The dermal skin protectant and carrier of claim 1 , wherein the at least one active agent is selected from the group consisting of: an antimicrobial agent, an anesthetic agent, a hemostatic agent, an anti-inflammatory agent, a hemp-based extract, a deodorant, a pain relief agent, a UV protection agent, and combinations thereof.

3. The dermal skin protectant and carrier of claim 2 , wherein two or more active agents are combined together in the dermal skin protectant and carrier.

4. The dermal skin protectant and carrier of claim 1 , wherein the ratio between the first dimethicone to the second dimethicone is between 100:1 and 1:10.

5. The dermal skin protectant and carrier of claim 1 , wherein the concentration of the at least one active agent is between 0.1 and 10%.

6. The dermal skin protectant and carrier of claim 2 , wherein said antimicrobial agent is an antifungal, antiviral, or antibacterial agent.

7. The dermal skin protectant and carrier of claim 1 , further comprising at least one essential oil.

8. The dermal skin protectant and carrier of claim 2 , wherein the antimicrobial agent is selected from the group consisting of: benzalkonium chloride, cetylpyridinium chloride, and combinations thereof.

9. A method of manufacturing a dermal skin protectant and carrier comprising: a first dimethicone material having a viscosity of between about 1,000 cP and 25,000 cP, and a second dimethicone material having a viscosity of between about 2.0 million and 3.0 million cP; and at least one active agent wherein the concentration of the first dimethicone material is between 47.5% and 92.5% of the weight of the skin protectant and carrier; the method comprising: placing the first dimethicone component into a mixing container and adding into it an amount of the active agent and mixing the combination at 3,000 RPM for about 10 minutes in a centripetal mixer; after mixing the at least one active agent into the first dimethicone, adding the second dimethicone to the mixing chamber, with a portion of the total concentration of the second dimethicone added in equal increments, followed by mixing at 3,000 RPM for five minute increments until all of the second dimethicone is added and mixed for five minutes.

10. The dermal skin protectant and carrier of claim 1 , wherein the active agent is an antifungal composition.

11. The dermal skin protectant and carrier of claim 10 , wherein he antifungal is selected from the group consisting of: clotrimazole, econazole, miconazole, terbinafine, fluconazole, ketoconaozole, mophotericin, nystatin, sporanox, difulcan, terazol, intraconazole, mycostatin, boric acid, ticonazole, undecylenic acid, tolnaftate, imidazole, luliconazole, tavaborole, allylamine, amorolfine, oxiconazole, gluconazole, ciclotirox, naftifine, amphotericin B, sulconazole, butenafine, sertaconazole, efinacanazole, a derivative or prodrug thereof, and combinations thereof.

12. The dermal skin protectant and carrier of claim 1 , wherein the composition further comprises Aloe vera.

13. The dermal skin protectant and carrier of claim 1 , wherein the active agent is a topical anesthetic.

14. The dermal skin protectant and carrier of claim 1 , wherein the active agent is a skin care material, and wherein the skin care material is selected from the group consisting of: chitosan, sulfadiazine, silver sulfadiazine, silver nitrate, silver nanoparticles and combinations thereof.

15. The dermal skin protectant and carrier of claim 13 , wherein the topical anesthetic is selected from the group consisting of: benzocaine, butamben, tetracaine, benzyl alcohol, capsaicin, dibucaine, diclofenac, dyclonine, ethyl chloride, hexylresorcinol, lidocaine, prilocaine, methyl salicylate, menthol, pramoxine, proparacaine, trolamine, and combination thereof.

16. The dermal skin protectant and carrier of claim 1 , wherein the active ingredient is a wound healing composition selected from the group consisting of: bacitracin, neomycin, polymyxin B, epidermal growth factor, triamcinolone, and combinations thereof.

17. The dermal skin protectant and carrier of claim 1 , wherein the active ingredient is a hemostatic composition selected from the group consisting of: tranexamic acid, chitosan, human fibrinogen, human thrombin, nonhuman fibrinogen or thrombin, synthetic fibrinogen or thrombin, keratin or combination thereof.

18. The dermal skin protectant and carrier of claim 1 , wherein the active ingredient is a ferric subsulfate material or Monsel's solution.

19. The dermal skin protectant and carrier of claim 1 , further comprising: an excipient, wherein said excipient is selected from the group consisting of: a moisturizer, flavor, pigment, essential oils, zinc oxide, a wetting agent, and combinations thereof.

20. The dermal skin protectant and carrier of claim 1 , wherein the active ingredient is an acne treating agent selected from the group consisting of: benzoyl peroxide, azelaic acid, salicylic acid, corticosteroids, retinoids, antibiotics, and combinations thereof.

21. The dermal skin protectant and carrier of claim 1 , wherein the active ingredient is a hemorrhoid treating agent selected from the group consisting of phenylephrine hydrochloride, pramoxine HCL, a corticosteroid, and combinations thereof.

22. The dermal skin protectant and carrier of claim 1 , wherein the active ingredient is a hemp-based extract, wherein said hemp-based extract comprises at least one cannabinoid.

23. The dermal skin protectant and carrier of claim 1 , wherein the active ingredient is an anti-inflammatory agent, and wherein said anti-inflammatory agent is selected from the group comprising diphenhydramine, corticosteroids, and combinations thereof.

24. The dermal skin protectant and carrier of claim 1 , wherein the active ingredient is an antimicrobial agent and wherein said antimicrobial agent is selected from the group consisting of an antifungal, antibiotic, or antiviral composition.

25. The dermal skin protectant and carrier of claim 1 , further comprising an excipient selected from the group consisting of: an oil, a fat, a wax, and combinations thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2024
From: INSPIRED MATERIAL SOLUTIONS, LLC
To: INSPIRED MATERIAL STRATEGIES, LLC
Reel/Frame 069477/0899 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2019
From: LATTA, MARK A.
To: INSPIRED MATERIAL SOLUTIONS, LLC
Reel/Frame 050978/0263 →
Continuity (3)
Provisional Application 62846763 · May 13, 2019
Provisional Application 62755719 · Nov 5, 2018
Related Publication 20200138958A1 · May 7, 2020
Cited By (1)
US 12,194,120